Related by context. All words. (Click for frequent words.) 83 myocardial infarction MI 74 acute myocardial infarction 73 ischemic stroke 71 coronary revascularization 71 unstable angina 71 infarction 71 acute coronary syndrome 70 reinfarction 70 coronary artery disease 70 left ventricular dysfunction 69 ischemic 69 myocardial infarction stroke 69 ischemic complications 69 acute myocardial infarction AMI 69 nonfatal MI 68 thrombotic events 68 coronary disease 68 repeat revascularization 68 myocardial infarctions 67 thromboembolism 67 ipsilateral stroke 67 revascularization 67 ST elevation myocardial 67 thromboembolic events 67 cardiovascular mortality 66 revascularisation 66 cardiogenic shock 66 myocardial ischemia 66 LV dysfunction 66 infarctions 66 acute coronary syndromes 65 coronary heart 65 nonfatal myocardial infarction 65 thromboembolic 65 nonischemic 65 unstable angina pectoris 65 postoperative AF 65 recurrent VTE 65 ischemic cardiomyopathy 64 cardiovascular disease 64 cerebrovascular events 64 CABG 64 recurrent ischemia 64 silent ischemia 64 LVEF 64 thrombotic complications 64 cardiovascular disease CVD 64 ischemia 64 fatal myocardial infarction 64 infarction STEMI 64 sudden cardiac death 64 stenting 63 coronary 63 acute coronary 63 infarct size 63 β blockers 63 VT VF 63 stroke transient ischemic 63 preserved ejection fraction 63 STEMI 63 cardiac dysfunction 63 periprocedural 63 carotid stenosis 63 arrhythmias 63 decompensated heart failure 63 atrial fibrillation AF 63 nonfatal stroke 63 ischemic strokes 63 NSTEMI 63 angina 62 HF hospitalization 62 systemic embolism 62 cardiovascular hospitalization 62 renal dysfunction 62 cerebral infarction 62 revascularization procedures 62 valvular disease 62 left ventricular systolic 62 Erythropoietic therapies may 62 statin therapy 62 target vessel revascularization 62 ventricular arrhythmia 62 systolic dysfunction 62 atherosclerotic disease 62 atrial fibrillation 62 MACCE 62 symptomatic VTE 62 thrombolytic therapy 62 infarct 62 binary restenosis 62 Myocardial Infarction 62 vertebral fracture 62 angina pectoris 62 STEMI patients 62 cerebral vasospasm 61 atherosclerosis 61 diabetes mellitus 61 Myocardial infarction 61 macrovascular disease 61 upper gastrointestinal bleeding 61 intracerebral hemorrhage 61 cardiac 61 VTE 61 arterial thromboembolic events 61 ventricular tachycardia VT 61 myocardial 61 LVSD 61 CABG surgery 61 atherothrombotic events 61 resuscitated cardiac arrest 61 hyperkalemia 61 recurrent stroke 61 left ventricular hypertrophy 61 MIs 61 lipid lowering therapy 61 rhythm disturbances 61 ICD implantation 61 eplerenone 61 tirofiban 61 severe hypoglycemia 61 stable angina 61 nonfatal heart 61 Acute Coronary Syndrome 61 troponin T 61 diastolic heart 61 biochemical recurrence 61 reperfusion therapy 61 cardiovascular 61 subclinical atherosclerosis 61 composite endpoint 61 glycated hemoglobin levels 61 multivessel disease 60 definite stent thrombosis 60 events MACE 60 venous thromboembolism 60 nondiabetic patients 60 nonfatal myocardial infarction MI 60 reperfusion 60 cerebrovascular 60 stent thromboses 60 antiplatelet therapy 60 syncope 60 hyperglycaemia 60 subclinical hypothyroidism 60 percutaneous coronary intervention 60 stent thrombosis 60 tachyarrhythmias 60 perioperative complications 60 microalbuminuria 60 coronary intervention 60 paroxysmal AF 60 infarcts 60 venous thrombosis 60 paclitaxel eluting stents 60 refractory ischemia 60 beta blocker therapy 60 vascular disease 60 thrombosis 60 macrovascular 60 atherosclerotic 60 hemorrhagic strokes 60 colorectal adenoma 60 NYHA Class II 60 revascularizations 60 acute coronary syndromes ACS 60 hypertensive 60 cardiovascular hospitalizations 60 sustained ventricular tachycardia 60 clopidogrel 60 acute myocardial infarctions 60 eptifibatide 60 CHD 60 restenosis 59 ischemia driven 59 bivalirudin 59 noncardiac 59 bypass grafting 59 contrast induced nephropathy 59 left ventricular ejection 59 atherothrombosis 59 XIENCE V PROMUS Stent 59 onset atrial fibrillation 59 elevated triglyceride levels 59 recurrent myocardial infarction 59 recurrent venous thromboembolism 59 atherothrombotic disease 59 hypercholesterolemia 59 undergoing CABG 59 torsades de pointes 59 thrombotic 59 renal insufficiency 59 cardiovascular morbidity 59 hypoxemia 59 antithrombotic therapy 59 rebleeding 59 noncardiac surgery 59 acute decompensation 59 TAVI 59 segment elevation myocardial 59 macrovascular events 59 TAXUS Express Stent 59 ejection fraction 59 fibrinolysis 59 ventricular dysfunction 59 arterial calcification 59 normotensive 59 cryptogenic stroke 59 ventricular tachycardia 59 aortic stenosis 59 postoperative atrial fibrillation 59 CMV disease 59 ventricular remodeling 59 revascularization procedure 59 carotid endarterectomy 59 platelet reactivity 59 PSADT 59 cardioembolic stroke 59 echocardiographic 58 acute ischemic stroke 58 postoperative complications 58 rehospitalization 58 fondaparinux 58 undergoing coronary artery 58 extrapyramidal symptoms 58 target lesion revascularization 58 ventricular function 58 cerebrovascular accident 58 platelet activation 58 interstitial pneumonia 58 postoperative complication 58 vertebral fractures 58 intracerebral haemorrhage 58 non valvular atrial 58 Ischemic 58 lacunar 58 STEMIs 58 rFVIIa 58 Events MACE 58 stent placement 58 myocardial infarct 58 periprocedural MI 58 Stent thrombosis 58 myocardial fibrosis 58 acute aortic dissection 58 coronary blockages 58 microvascular complications 58 severe hypoglycemic 58 thrombocytopenic 58 embolic stroke 58 candesartan 58 microvascular disease 58 stented 58 invasive candidiasis 58 variceal bleeding 58 albuminuria 58 valsartan 58 Venous thromboembolism 58 endarterectomy 58 patients undergoing percutaneous 58 stent implantation 58 Percutaneous Coronary Intervention 58 severe exacerbations 58 ACE inhibitors 58 PCa 58 undergoing coronary angiography 58 postoperative mortality 58 left ventricular LV 58 fragility fracture 58 olmesartan 58 recurrent DVT 58 patients undergoing CABG 58 carotid atherosclerosis 58 carotid intima media 58 dobutamine 58 carotid artery disease 58 Lp PLA2 58 prostate cancer CaP 58 urgent coronary revascularization 58 cerebral ischemia 57 alteplase 57 DMARD 57 ximelagatran 57 ivabradine 57 coronary artery bypass 57 fibrinolytic 57 NATRECOR R 57 hypoperfusion 57 neointimal hyperplasia 57 kidney transplant recipients 57 peptide BNP 57 ventricular tachyarrhythmia 57 systolic hypertension 57 haemorrhagic stroke 57 pericardial effusion 57 ventricular fibrillation VF 57 asymptomatic PAD 57 thrombolysis 57 intracoronary 57 transient ischemic attack 57 autonomic dysfunction 57 reperfusion injury 57 CVD mortality 57 noncardiovascular mortality 57 coronary atherosclerosis 57 ischaemia 57 subclinical hyperthyroidism 57 asystole 57 ATACAND 57 de ath 57 TAXUS Stent 57 coronary artery revascularization 57 colectomy 57 venous thromboembolism VTE 57 ABCB1 57 TEAEs 57 proliferative diabetic retinopathy 57 platelet inhibition 57 thromboembolic complications 57 ICD implants 57 aortic 57 unstable angina UA 57 stenosis 57 tumor recurrence 57 ventricular arrhythmias 57 sinus rhythm 57 DES implantation 57 coronary interventions 57 coronary angiography 57 fibrinolytic therapy 57 hyperglycemia 57 peri procedural 57 diastolic dysfunction 57 venous thromboembolic events 57 aspirin clopidogrel 57 thyrotoxicosis 57 renal artery stenosis 57 cerebrovascular disease 57 nephropathy 57 arrhythmia 57 NNT = 57 KIF6 carriers 57 lipid lowering drugs 57 dysfunction LVSD 57 endothelial activation 57 angioplasty stenting 57 perioperatively 57 hemorrhagic complications 57 angina chest 57 T2DM 57 serum cholesterol 57 antiplatelet agents 57 proteinuria 57 nondiabetics 57 antiplatelet drugs 57 aortic valve stenosis 57 myocardial infarctions MI 57 intracerebral hemorrhage ICH 57 Taxus Stent 57 colorectal adenomas 57 ruptured aneurysms 57 hypercholesterolaemia 57 Hemorrhagic stroke 57 reintervention 57 atherothrombotic 57 T1DM 57 carotid artery blockage 57 adenoma 57 losartan 57 coronary stenosis 57 ejection fractions 57 acute myocardial infarction MI 57 endothelial dysfunction 57 NYHA class 56 MGUS 56 intima media thickness 56 NSTE ACS 56 Hypotension 56 symptomatic intracranial 56 antiarrhythmic drug 56 salmeterol HFA MDI 56 cilostazol 56 carotid plaque 56 virologic failure 56 atrioventricular valve 56 angiographically 56 carotid artery stenting 56 postoperative pulmonary 56 HbA1c levels 56 % CI #.#-#.# [006] 56 heart disease 56 spontaneous preterm delivery 56 intravenous bisphosphonates 56 recanalization 56 reblockage 56 carotid plaques 56 Val HeFT 56 severe neutropenia 56 OPCAB 56 carotid artery stenosis 56 thiazide diuretics 56 thrombus aspiration 56 hyperacute 56 anticoagulation 56 angiotensin converting enzyme inhibitors 56 Atherosclerotic 56 atherosclerotic lesions 56 sinus node dysfunction 56 XIENCE V vs. 56 arterial thrombosis 56 primary percutaneous coronary 56 hemodynamic instability 56 invasive aspergillosis 56 ECG abnormalities 56 liver transplant recipients 56 intensive statin therapy 56 perioperative mortality 56 infarction NSTEMI 56 artery stenosis 56 thrombolytics 56 diabetes mellitus DM 56 dyssynchrony 56 hip fracture 56 Cypher Stent 56 lactic acidosis 56 death reinfarction 56 intracranial hemorrhage ICH 56 ischemic heart 56 nonvertebral fractures 56 onset diabetes mellitus 56 beta blockers 56 recurrent atrial fibrillation 56 MetS 56 prolonged QT interval 56 artery reclogging 56 vascular inflammation 56 carotid IMT 56 pioglitazone 56 bypass graft CABG surgery 56 bradycardia 56 atheroma volume 56 Myocardial Infarction MI 56 myocardial ischaemia 56 renal function 56 statins 56 TNF antagonist 56 atrial arrhythmias 56 tumor lysis syndrome 56 troponin 56 ventricular fibrillation 56 recurrent ischemic 56 Thrombolysis 56 TIA transient ischemic 56 antihypertensive therapy 56 adrenalectomy 56 asymptomatic carotid stenosis 56 antiarrhythmic drugs 56 pacemaker implantation 56 thromboprophylaxis 56 endometrial hyperplasia 56 malperfusion 56 severe psoriasis 56 venous thromboembolisms 56 circulating EPCs 56 QRS duration 56 nephrotoxicity 56 CP CPPS 56 angiographic restenosis 56 aneurysmal subarachnoid hemorrhage 56 diastolic function 56 nonvertebral fracture 56 carotid artery stenting CAS 56 dual antiplatelet therapy 56 thrombophilia 56 androgen deprivation 56 valvular heart disease 56 glomerular filtration 56 XIENCE V demonstrated 56 heparin induced thrombocytopenia 56 atrioventricular block 56 intraventricular hemorrhage 56 systolic function 56 NMIBC 56 hyperhomocysteinemia 56 tenecteplase 56 aortic dissections 56 occlusive disease 56 enoxaparin 56 morphometric vertebral fractures 56 acute cholecystitis 56 myocardial infraction 56 white matter hyperintensities 55 lipid lowering medications 55 sirolimus eluting stents 55 cardiopulmonary bypass 55 inhospital 55 APOE e4 55 aortic regurgitation 55 Acute Myocardial Infarction 55 breast cancer recurrence 55 cTnT 55 ADHF 55 fatal arrhythmic 55 diabetic kidney 55 syncopal 55 biochemical relapse 55 coronary artery bypass grafting 55 vasospasm 55 systolic 55 paroxysmal atrial fibrillation 55 acute ischemic 55 hypertension 55 aldosterone antagonists 55 adalimumab 55 proximal DVT 55 glycoprotein IIb IIIa inhibitors 55 resynchronization therapy 55 ARCOXIA 55 coronary artery calcium 55 ACE inhibitor 55 hypoglycemic episodes 55 venous blood clots 55 endophthalmitis 55 acute renal failure 55 hypertensives 55 pneumonectomy 55 nonobstructive CAD 55 serum creatinine levels 55 elevated CRP 55 diameter stenosis 55 stable angina pectoris 55 atherosclerotic cardiovascular disease 55 tHcy 55 hsCRP 55 IPAH 55 valvular 55 MI myocardial infarction 55 abciximab 55 progressive dyspnea 55 elective PCI 55 rs# [002] 55 macroalbuminuria 55 DAPT 55 advanced adenoma 55 posttransplant 55 stenoses 55 cardiac troponin 55 underwent CABG 55 Kaplan Meier analysis 55 nonfasting triglyceride levels 55 percutaneous intervention 55 P = .# 55 noncardiovascular 55 streptokinase 55 hypercalcemia 55 angiotensin II receptor blockers 55 dysglycemia 55 reoperations 55 metabolic syndrome 55 nesiritide 55 CTEPH 55 hypertensive patients 55 decompensation 55 recurrent miscarriage 55 neurologic complications 55 aldosterone antagonist 55 colorectal liver metastases 55 LV hypertrophy 55 beta blocker 55 abnormal heartbeats 55 defibrillator CRT D 55 Unstable Angina 55 rosuvastatin #mg 55 CK MB 55 UA NSTEMI 55 arterial stiffness 55 coronary artery bypass grafts 55 serum calcium levels 55 TAXUS 55 NATRECOR ® 55 nonfasting triglycerides 55 statin 55 intracranial stenosis 55 recurrent coronary 55 hypoglycemic events 55 cerebrovascular accidents 55 carotid 55 antithrombotic 55 thromboembolic disease 55 nicardipine 55 surgical revascularization 55 carotid stenting 55 VTEs 55 ICD shocks 55 Unstable angina 55 CABG coronary artery 55 ischemic cerebrovascular 55 target lesion revascularizations 55 comorbidities 55 familial hypercholesterolemia 55 Major Adverse Cardiac 55 cirrhotic patients 55 angiotensin receptor blockers 55 fasting glucose levels 55 intracerebral hemorrhages 55 overt nephropathy 55 secondary endpoint 55 antithrombotic therapies 55 CMV infection 55 myocardial infarctions MIs 55 HeFH 55 radical nephrectomy 55 nonresponders 55 confidence interval CI 55 HSCT 55 severe aortic stenosis 55 airway hyperresponsiveness 55 coronary vascular 55 platelet aggregation 54 asthma exacerbation 54 ticlopidine 54 2 diabetes T2D 54 tPA 54 leukocyte count 54 ICDs implanted 54 Torsades de Pointes 54 impaired fasting glucose 54 NGAL 54 arterial hypertension 54 QT prolongation 54 ischemic vascular 54 Statin therapy 54 EXJADE 54 Renal dysfunction 54 liver resection 54 hemorrhagic stroke 54 cardiac resynchronization 54 multivariate adjustment 54 D dimer 54 asymptomatic 54 transurethral resection 54 TAXUS p value 54 fibrillation 54 postoperative delirium 54 arteriography 54 hepatotoxicity 54 nonadherence 54 hsCRP levels 54 nonsignificant 54 ischemic cardiovascular 54 angiotensin converting enzyme inhibitor 54 systolic BP 54 artery blockages 54 myocardial reperfusion 54 hyperparathyroidism 54 incomplete revascularization 54 Arrhythmias 54 drug eluting stent implantation 54 dronedarone 54 cardiac tamponade 54 cardiomyopathies 54 thrombo embolic 54 idraparinux 54 SSc 54 sotalol 54 coronary revascularization procedures 54 triglyceride levels 54 preterm delivery 54 TACE 54 pancreatectomy 54 simvastatin ezetimibe 54 lispro 54 STEMI ST 54 PLX STROKE targeting 54 coronary thrombosis 54 elevated LDL cholesterol 54 necrotizing pancreatitis 54 sirolimus stent 54 CYPHER Stent 54 postprocedure 54 lobectomy 54 nonischemic cardiomyopathy 54 hypoglycemia 54 dyslipidaemia 54 VADT 54 angiotensin receptor blockers ARBs 54 everolimus eluting stents 54 IIIa inhibitor 54 verapamil 54 warfarin therapy 54 clot busting therapy 54 comorbid conditions 54 recurrent glioblastoma multiforme 54 cerebral perfusion 54 ischemia reperfusion injury 54 TAXUS stent 54 mitral regurgitation 54 cardiac toxicity 54 bronchopulmonary dysplasia 54 severe sepsis 54 CYPHER ® Stent 54 leiomyomas 54 chronic thromboembolic pulmonary 54 saphenous vein grafts 54 perimenopausal women 54 induce orthostatic hypotension 54 dose atorvastatin 54 vasculopathy 54 cardiac insufficiency 54 intermittent claudication 54 vasovagal syncope 54 coagulopathy 54 PSVT 54 hyperalgesia 54 microbleeds 54 vessel occlusion 54 distensibility 54 coronary artery 54 lipid lowering agents 54 serum creatinine 54 QTc intervals 54 polyp recurrence 54 Ventricular Tachycardia 54 ranolazine 54 antiplatelet agent 54 hypertriglyceridemia 54 cardiovascular ischemic 54 noncarriers 54 ST Segment Elevation 54 glitazones 54 cholecystectomy 54 subarachnoid hemorrhage SAH 54 nodal metastases 54 MADIT 54 Ischemic stroke 54 hyperlipidaemia 54 cryptogenic 54 elevated triglycerides 54 cardiovascular diseases 54 Pioglitazone 54 adenomas 54 comorbidity 54 invasive coronary angiography 54 venous thromboembolic disease 54 repolarization 54 infective endocarditis 54 LOVENOX 54 nontraumatic 54 atrial 54 hypertension diabetes mellitus 54 thrombolytic agents 54 distant metastasis 54 intracranial atherosclerosis 54 Fonarow 54 gouty arthritis 54 intracranial aneurysm 54 SORT OUT III 54 transient ischemic attacks 54 mm Hg 54 chronic pancreatitis 54 adrenal insufficiency 54 warfarin 54 hepatectomy 54 PNH patients 54 myocardial infarction ventricular fibrillation 54 percutaneous coronary interventions 54 advanced neoplasia 54 haemorrhagic strokes 54 TAVR 54 abnormal uterine bleeding 54 recurrent wheezing 54 nadolol 54 sirolimus eluting stent 54 disease progression 54 rate variability HRV 54 unfractionated heparin 54 oral hypoglycemic agents 54 exacerbations 54 underwent coronary angiography 54 intimal hyperplasia 54 torsade de pointes 54 QTc 54 intravenous diuretics 54 tissue plasminogen activator tPA 54 aortic stiffness 54 cardiac biomarkers 54 Peripheral arterial disease 54 metastatic malignant 54 confidence interval #.#-#.# 54 Prehypertension 54 elevated homocysteine 54 corticosteroid therapy 54 coronary revascularizations 54 pathophysiologic 54 artery blockage 54 pathologic fractures 54 invasive fungal infection 54 glucose lowering 54 QTc interval 54 undergoing angioplasty 54 mixed hyperlipidemia 54 urine NGAL 54 unfractionated heparin UFH 54 mmol L 54 arrythmias 54 % CI #.#-#.# [003] 54 hypotension 54 isolated systolic hypertension 54 lymphocyte counts 54 post thrombotic syndrome 54 afib 54 adenomatous polyps 54 angiotensin converting enzyme ACE 54 PAOD 54 hyperlipidemia 54 prostate cancer PCa 54 artery calcification 54 leukotriene pathway 54 Lactic acidosis 54 triglyceride concentrations 54 stroke myocardial infarction 54 Operative mortality 54 osteonecrosis 54 subclinical 54 silent myocardial ischemia 54 intracerebral 54 SCr 53 VTE prophylaxis 53 CHD CVD 53 pCR 53 NIHSS score 53 p = #.# [004] 53 hepatocellular carcinoma HCC 53 ramipril 53 cytopenias 53 postoperative morbidity 53 NIDDM 53 parathyroidectomy 53 arrhythmogenic 53 QTc prolongation 53 CVD 53 ARIXTRA 53 p = #.# [002] 53 Restenosis 53 claudication 53 coronary insufficiency 53 ventricular tachyarrhythmias 53 endovascular repair 53 virologic response 53 Antihypertensive 53 ventricular 53 highest tertile 53 chlorambucil 53 tolvaptan 53 prognostic significance 53 Coronary Artery Bypass Graft 53 nondiabetic 53 Ranolazine 53 AA Amyloidosis 53 Severe hypoglycemia 53 antihypertensive agents 53 hepatocellular carcinomas 53 Aortic stenosis 53 gestational hypertension 53 microvascular 53 cerebral vascular disease 53 carotid bruit 53 prospectively defined 53 subarachnoid hemorrhages 53 hemodilution 53 perindopril 53 liver histology 53 atherogenic dyslipidemia 53 rtPA 53 abnormal glucose tolerance 53 CYPHER R Stent 53 parkinsonian symptoms 53 lung fibrosis 53 confirmed thrombotic cardiovascular 53 #.#/#.# mmHg [001] 53 locoregional recurrence 53 bezafibrate 53 lethal arrhythmias 53 hepatic metastases 53 Infarction 53 Acute Coronary Syndromes ACS 53 coronary occlusion 53 GISTs 53 HNSCC 53 extubation 53 ACEI ARB 53 recombinant tissue plasminogen 53 coronary artery bypass graft 53 spinal cord compression 53 atheroma 53 inflammatory rheumatic 53 nonrandomized 53 fluvastatin 53 NYHA Class III 53 pulmonary artery banding 53 ventricular mass 53 carvedilol 53 malignant neoplasm 53 diabetic gastroparesis 53 electrical cardioversion 53 soluble CD# ligand 53 advanced adenomas 53 mycophenolate mofetil 53 atrophic gastritis 53 thienopyridines 53 Hashimoto thyroiditis 53 radical prostatectomy 53 NT proBNP 53 persistent pulmonary hypertension 53 metastatic renal cell carcinoma 53 paricalcitol 53 retransplantation 53 rosuvastatin 53 stent thrombosis blood clots 53 gastrointestinal cancers 53 abdominal adiposity 53 endothelial function 53 arterial revascularization 53 neurologic symptoms 53 artery occlusion 53 plaque rupture 53 postmenopausal breast cancer 53 deep venous thromboses 53 gout flares 53 Nesiritide 53 clopidogrel Plavix 53 lipid levels 53 oesophageal adenocarcinoma 53 azacitidine 53 Bivalirudin 53 radical prostatectomy RP 53 stent restenosis 53 proliferative retinopathy 53 fractional shortening 53 HMG CoA reductase inhibitors 53 colorectal carcinoma 53 transcatheter closure 53 fulminant hepatitis 53 preserved systolic 53 Aortic Stenosis 53 myocardial perfusion 53 cerebral microbleeds 53 primary aldosteronism 53 celecoxib 53 COPD exacerbation 53 Thromboembolism 53 Carotid Revascularization Endarterectomy vs. 53 urolithiasis 53 tibolone 53 gallstone disease 53 bioprostheses 53 Asymptomatic 53 MADIT II 53 CYP#C# [001] 53 anastomotic leak 53 venous thromboembolic 53 pressor response 53 computed tomography angiography 53 prothrombotic 53 ß blockers 53 AVANDIA 53 thromboembolic disorders 53 virological response 53 cTnI 53 Thrombocytopenia 53 primidone 53 pulmonary thromboembolism 53 postoperative 53 prespecified 53 thromboses 53 Coronary artery bypass grafting 53 cystectomy 53 serum potassium 53 antiplatelet medications 53 breast carcinoma 53 CHD mortality 53 C reactive protein 53 spontaneous preterm birth 53 anterior uveitis 53 iodixanol 53 tamponade 53 VaD 53 eGFR 53 β blocker 53 femoral neck fracture 53 peripheral arterial disease 53 conventional coronary angiography 53 Acute Coronary Syndromes 53 preoperative PSA 53 MADRS score 53 myocardial infarcts 53 CC genotype 53 urgent revascularization 53 symptomatic atrial fibrillation 53 IDDM